Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension
Lewis J. Rubin(University of California San Diego), Robyn J. Barst(Columbia University), Michael Oakes(Pfizer (United Kingdom)), David B. Badesch(University of Colorado Anschutz Medical Campus), Vallerie V. McLaughlin(University of Michigan), Gary Layton(University of Geneva), Nazzareno Galiè(Azienda USL di Bologna), Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Thomas R. Fleming(University of Washington), Gérald Simonneau(Inserm), Marjana Serdarevic-Pehar(Jagiellonian University)
Cited by 257
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Survival in Patients with Primary Pulmonary Hypertension
|Annals of Internal Medicine|1991|3.5k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k